GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Venus Remedies Ltd (BOM:526953) » Definitions » Gross Profit

Venus Remedies (BOM:526953) Gross Profit : ₹2,468 Mil (TTM As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Venus Remedies Gross Profit?

Venus Remedies's gross profit for the three months ended in Mar. 2024 was ₹751 Mil. Venus Remedies's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was ₹2,468 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Venus Remedies's gross profit for the three months ended in Mar. 2024 was ₹751 Mil. Venus Remedies's Revenue for the three months ended in Mar. 2024 was ₹1,952 Mil. Therefore, Venus Remedies's Gross Margin % for the quarter that ended in Mar. 2024 was 38.49%.

Venus Remedies had a gross margin of 38.49% for the quarter that ended in Mar. 2024 => Competition eroding margins

During the past 13 years, the highest Gross Margin % of Venus Remedies was 45.51%. The lowest was 33.22%. And the median was 40.27%.

Warning Sign:

Venus Remedies Ltd gross margin has been in long-term decline. The average rate of decline per year is -3.7%.


Venus Remedies Gross Profit Historical Data

The historical data trend for Venus Remedies's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Venus Remedies Gross Profit Chart

Venus Remedies Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,544.45 1,961.66 1,988.80 2,245.20 2,467.60

Venus Remedies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 686.70 472.10 702.00 542.30 751.20

Competitive Comparison of Venus Remedies's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Venus Remedies's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Venus Remedies's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Venus Remedies's Gross Profit distribution charts can be found below:

* The bar in red indicates where Venus Remedies's Gross Profit falls into.



Venus Remedies Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Venus Remedies's Gross Profit for the fiscal year that ended in Mar. 2024 is calculated as

Gross Profit (A: Mar. 2024 )=Revenue - Cost of Goods Sold
=6014.5 - 3546.9
=2,468

Venus Remedies's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=1951.6 - 1200.4
=751

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2,468 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Venus Remedies's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=751 / 1951.6
=38.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Venus Remedies  (BOM:526953) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Venus Remedies had a gross margin of 38.49% for the quarter that ended in Mar. 2024 => Competition eroding margins


Venus Remedies Gross Profit Related Terms

Thank you for viewing the detailed overview of Venus Remedies's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Venus Remedies (BOM:526953) Business Description

Traded in Other Exchanges
Address
Plot 51-52, Industrial Area, Phase 1, Panchkula, HR, IND, 134113
Venus Remedies Ltd is an Indian drug manufacturer. It is engaged in manufacturing and trading pharmaceutical products. The company produces biologically active food supplements which include food supplements are natural complexes containing minerals, vitamins, dietary fibers, extracts of medicinal herbs, amino acids, and others.

Venus Remedies (BOM:526953) Headlines

No Headlines